Author

Parvind Sheokand

Institution: All India Institute of Medical Sciences

Observed institution: All India Institute of Medical Sciences

ORCID: 0000-0003-4589-2623

Observed ORCID: 0000-0003-4589-2623

OpenAlex ID: A5033332224

Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers

2023 · Sanjana Ballal, Madhav P. Yadav, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 34

Head-to-Head Comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]F-FDG PET/CT Imaging in Patients with Breast Cancer

2023 · Sanjana Ballal, Madhav P. Yadav, et al. · Pharmaceuticals · 33

Head-to-Head Comparison of [ 68 Ga]Ga-DOTA.SA.FAPi and [ 68 Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer

2023 · Sanjana Ballal, Madhav Prasad Yadav, et al. · Thyroid · 32

Head-to-Head Comparison of SSTR Antagonist [68Ga]Ga-DATA5m-LM4 with SSTR Agonist [68Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study

2024 · Rahul Viswanathan, Sanjana Ballal, et al. · Pharmaceuticals · 14

[111In]In/[177Lu]Lu-AAZTA5-LM4 SST2R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results

2023 · Berthold A. Nock, Panagiotis Kanellopoulos, et al. · Pharmaceutics · 11

Biodistribution and Dosimetry Evaluation of the Radiolabeled Somatostatin Receptor Antagonist 68Ga-DATA5m LM4 in Molecular Imaging of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Patients

2025 · Sanjana Ballal, Parvind Sheokand, et al. · Clinical Nuclear Medicine · 1

Works count: 6

Citation count: 125

H-index: 5

I10-index: 5